This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • GCPGC in Chemotherapy-induced Neutropenia
Clinical trial

GCPGC in Chemotherapy-induced Neutropenia

Read time: 1 mins
Last updated:6th Feb 2011
This study is adaptive design and it consists of stage I and stage II. Stage I is multi-center, parallel-group, single-blind, phase II study to determine the adequate dose of GCPGC and stage II is multi-center, parallel-group, open label,phase III study to evaluate the efficacy and safety of once per cycle GCPGC in chemotherapy-induced neutropenia compared to daily filgrastim
Category Value
Study start date 2011-02-06

View full details